Literature DB >> 18362302

Daily insulin requirement of children and adolescents with type 1 diabetes: effect of age, gender, body mass index and mode of therapy.

Susanna Wiegand1, Klemens Raile, Thomas Reinehr, Sabine Hofer, Andrea Näke, Wolfgang Rabl, Reinhard W Holl.   

Abstract

DESIGN: The purpose of this study was to generate insulin dose (ID) percentiles for children and adolescents with type 1 diabetes mellitus (DM1) having the opportunity to assess this important parameter in relation to age and sex.
METHODS: Daily IDs per weight (ID/kg) were recorded in 22,177 patients with DM1 (3-25 years of age, DM1 duration of more than 2 years, 48% female) and ID percentiles (ID-Perc) were created statistically. The ID-Perc were compared between male and female, and between multiple insulin injection therapy (MIT) and continuous s.c. insulin infusion (CSII). A multivariate regression analysis was performed for ID in the third year of DM1 with ID/kg, body weight, age, gender, and insulin delivery regimen as variables.
RESULTS: The 50th ID-Perc (P50) varied among 0.67 IU/kg (age 3 years), 0.93 IU/kg (13 years), and 0.70 IU/kg (23 years) increasing from early childhood to adolescence and decreasing toward adulthood. Highest P50 ID was found at 12 years in females (0.94 IU/kg) and at 14 years in males (0.92 IU/kg). Using ICT, the ID was significantly higher compared with CSII (P50: 0.94 IU/kg versus 0.79 IU/kg at 13 years). In multivariate regression analysis, ID was significantly (P>0.001) associated with age, gender, and insulin delivery regime.
CONCLUSION: The ID-Perc were significantly different during various periods of childhood and were influenced by gender, body weight, and insulin injection regimes. Therefore, the presented data 1) provide evidence to interpret individual ID in children and adolescents with DM1 and 2) more specifically identify children with unusually high (insulin resistance and non-compliance) or low (MODY and persistent remission) insulin requirement.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18362302     DOI: 10.1530/EJE-07-0904

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  13 in total

1.  Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.

Authors:  G H Teló; C E Dougher; L K Volkening; M L Katz; L M Laffel
Journal:  Diabet Med       Date:  2018-06-19       Impact factor: 4.359

2.  Insulin Glargine Dose and Weight Changes in Underweight, Normal Weight, and Overweight Children Newly Diagnosed with Type 1 Diabetes Mellitus.

Authors:  Bethany Sharpless Chalk; Janet Crane; Gayane Yenokyan; Erika May Pineda; Carlton K K Lee
Journal:  Pharmacotherapy       Date:  2019-06-06       Impact factor: 4.705

3.  Comparable efficacy and safety of insulin glulisine and insulin lispro when given as part of a Basal-bolus insulin regimen in a 26-week trial in pediatric patients with type 1 diabetes.

Authors:  Areti Philotheou; Silva Arslanian; László Blatniczky; Valentina Peterkova; Elisabeth Souhami; Thomas Danne
Journal:  Diabetes Technol Ther       Date:  2011-02-03       Impact factor: 6.118

4.  Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.

Authors:  Eda Cengiz; Peiyao Cheng; Katrina J Ruedy; Craig Kollman; William V Tamborlane; Georgeanna J Klingensmith; Robin L Gal; Janet Silverstein; Joyce Lee; Maria J Redondo; Roy W Beck
Journal:  Pediatr Diabetes       Date:  2016-10-19       Impact factor: 4.866

5.  Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation.

Authors:  Inas H Thomas; Natinder K Saini; Amita Adhikari; Joyce M Lee; Josephine Z Kasa-Vubu; Delia M Vazquez; Ram K Menon; Ming Chen; Stefan S Fajans
Journal:  Pediatr Diabetes       Date:  2009-06-03       Impact factor: 4.866

6.  Exogenous insulin requirements do not differ between youth and adults with cystic fibrosis related diabetes.

Authors:  Muna Sunni; Melena D Bellin; Antoinette Moran
Journal:  Pediatr Diabetes       Date:  2013-01-28       Impact factor: 4.866

7.  The influence of patient variables on insulin total daily dose in paediatric inpatients with new onset type 1 diabetes mellitus.

Authors:  Marion Muller; Benjamin J Wheeler; Miranda Blackwell; Mathilde Colas; David M Reith; Natalie J Medlicott; Hesham S Al-Sallami
Journal:  J Diabetes Metab Disord       Date:  2018-09-17

8.  Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery.

Authors:  Klemen Dovc; Charlotte Boughton; Martin Tauschmann; Hood Thabit; Lia Bally; Janet M Allen; Carlo L Acerini; Sabine Arnolds; Carine de Beaufort; Richard M Bergenstal; Fiona Campbell; Amy Criego; David B Dunger; Daniella Elleri; Mark L Evans; Elke Fröhlich-Reiterer; Sabine Hofer; Thomas Kapellen; Lalantha Leelarathna; Thomas R Pieber; Birgit Rami-Merhar; Viral N Shah; Judy Sibayan; Malgorzata E Wilinska; Roman Hovorka
Journal:  Diabetes Care       Date:  2019-05-21       Impact factor: 19.112

9.  Evolution of renal hyperfiltration and arterial stiffness from adolescence into early adulthood in type 1 diabetes.

Authors:  David Z I Cherney; Etienne B Sochett
Journal:  Diabetes Care       Date:  2011-06-02       Impact factor: 19.112

10.  Levothyroxine and insulin requirement in autoimmune polyglandular type 3 syndrome: a real-life study.

Authors:  V Guarnotta; G Pillitteri; G Gambino; S Radellini; E Vigneri; G Pizzolanti; C Giordano
Journal:  J Endocrinol Invest       Date:  2020-10-24       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.